Malin Corporation plc (ISE:MLC) acquired 80% stake in Cilatus BioPharma AG on November 18, 2016. Johannes Roebers, will join the Executive Team of Malin reporting to Kelly Martin. In addition, Johannes Roebers will continue to manage the Cilatus business on a day-to-day basis with his team of consultants. Brian Garrahy and Daragh O'Reilly of Davy Corporate Finance Limited acted as a financial advisors to Malin. Malin Corporation plc (ISE:MLC) completed the acquisition of 80% stake in Cilatus BioPharma AG for €0.8 million on November 18, 2016. Total consideration includes deferred contingent payment of €0.3 million. Malin Corporation plc has an option to acquire remaining 20% stake under call option based on future EBITDA targets met.